Stroke prevention: What's new?

Internal Medicine Journal

Volumn 33, Issue 4, 2003, Pages 177-181

  Gerraty, R P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin converting enzyme inhibitors; Aspirin; Cerebrovascular disorders; Clopidogrel; HMG CoA reductase inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; PERINDOPRIL; PERSANTIN SR; PRAVASTATIN; SIMVASTATIN; WARFARIN;

ANGIOPLASTY; ANTICOAGULATION; BLEEDING; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; IMAGE ANALYSIS; PRIORITY JOURNAL; REVIEW; STENT; STROKE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; ENDARTERECTOMY, CAROTID; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS;

EID: 0038016839     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2003.00375.x     Document Type: Review

References (28)

1. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-53.
2. PROGRESS Collaborative Group. Randomized trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
3. Anonymous. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
4. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D et al. Pravastatin therapy and the risk of stroke. N Engl J Med 2000; 343: 317-26.
5. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D et al. Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering Study I. Effects of atorvastatin on early recurrent ischaemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711-8.
6. Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Li T et al. Identification of major ischaemic change. Diffusion-weighted imaging versus computed tomography. Stroke 1999; 30: 2059-65.
7. Dovey Z, Misra M, Thornton J, Charbel FT, Debrun GM, Ausman JI. Guglielmi detachable coiling for intracranial aneurysms: the story so far. Arch Neurol 2001; 58: 559-64.
8. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. AHA scientific statement: supplement to the guidelines for the management of transient ischaemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischaemic Attacks, Stroke Council, American Heart Association. Stroke 1999; 30: 2502-11.
9. Anonymous. Collaborative overview of randomized trials of antiplatelet therapy - I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Br Med J 1994; 308: 81-106.
10. Algra A, Koudstaal PJ, van Gijn J. Secondary prevention following cerebral ischaemia: is monotherapy with acetylsalicylic acid still first choice? Ned Tijdschr Geneeskd 1998; 142: 277-80.
11. Taylor DW, Barnett HJ, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial. ASA Carotid Endarterectomy (ACE) Trial Collaborators. Lancet 1999; 353: 2179-84.
12. Hart RG, Halperin JL, McBride R, Benavente O, Man-Son-Hing M, Kronmal RA. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol 2000; 57: 326-32.
13. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 1998; 351: 1755-62.
14. Anonymous. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996; 348: 1329-39.
15. Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 2001; 103: 363-8.
16. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial I. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
17. Albers GW, Amarenco P. Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascular patients? Stroke 2001; 32: 2948-9.
18. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
19. Anonymous. Major ongoing stroke trials. Stroke 2001; 32: 2448-57.
20. Anonymous. A randomized trial of anticoagulants versus aspirin after cerebral ischaemia of presumed arterial origin. The Stroke Prevention in Reversible Ischaemia Trial (SPIRIT) Study Group. Ann Neurol 1997; 42: 857-65.
21. Mohr JP, Thompson JLP, Lazar RM, Levin B, Sacco RL, Furie KL et al. A comparison of warfarin and aspirin for the prevention of recurrent ischaemic stroke. N Engl J Med 2001; 345: 1444-51.
22. Byington RP, Davis BR, Plehn JF, White HD, Baker J, Cobbe SM et al. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation 2001; 103: 387-92.
23. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 7-22.
24. Anonymous. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325: 445-53.
25. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-25.
26. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis study. JAMA 1995; 273: 1421-8.
27. Anonymous. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet 2001; 357: 1729-37.
28. Mas J-L, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-6.